The Ozempic shortage is over, says FDA
The Semaglutide Outlook: A Closer Look at Global and Australian Trends The landscape for GLP-1 receptor agonists like Ozempic and Wegovy is rapidly evolving. Understanding these trends is crucial as pharmaceutical companies, healthcare providers, and patients navigate supply issues and regulatory changes. What’s Happening Overseas? In the United States, the FDA has declared the Ozempic … Read more